UICC World Cancer Congress

UICC World Cancer Congress
Name	UICC World Cancer Congress
Caption	Logo of the World Cancer Congress
Formation	1933
Headquarters	Geneva
Location	International
Leader title	Convening organisation
Leader name	Union for International Cancer Control

UICC World Cancer Congress The UICC World Cancer Congress is a recurring global convening led by the Union for International Cancer Control that assembles representatives from World Health Organization, International Agency for Research on Cancer, United Nations, GAVI, the Vaccine Alliance, Bill & Melinda Gates Foundation and other stakeholders to advance international cancer control. The Congress brings together delegates from national cancer institutes such as National Cancer Institute (United States), regional bodies like European Cancer Organisation, advocacy groups such as American Cancer Society and research networks including ACCORD. It functions as a forum linking policy-makers from Ministry of Health (France), funders like Wellcome Trust and implementers from Médecins Sans Frontières.

Overview

The Congress operates as a flagship event of the Union for International Cancer Control and is attended by representatives from organizations such as International Agency for Research on Cancer, World Health Organization, Organisation for Economic Co-operation and Development, World Bank, Global Fund to Fight AIDS, Tuberculosis and Malaria and professional societies like American Society of Clinical Oncology, European Society for Medical Oncology and International Association for the Study of Lung Cancer. Sessions often convene delegations from national bodies including Public Health England, Centers for Disease Control and Prevention, National Institutes of Health and academic institutions like Harvard Medical School, University of Oxford, Johns Hopkins University, University of Tokyo and University of Cape Town. The programme integrates contributions by cancer researchers from Dana-Farber Cancer Institute, policy experts from Rockefeller Foundation, and civil society leaders from Union for International Cancer Control member organisations.

History and development

The Congress traces its lineage to early 20th-century international gatherings on oncological practice and evolved alongside institutions such as Union for International Cancer Control, International Agency for Research on Cancer and the postwar United Nations system including World Health Organization. Early predecessors intersected with scientific milestones at centres like Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center and conferences linked to figures such as Marie Curie and Paul Ehrlich. Over decades the event expanded amid health diplomacy efforts by actors like World Health Organization and funders including Wellcome Trust, Gates Foundation and Bloomberg Philanthropies. Technological and thematic shifts reflect contributions from CRUK, National Cancer Institute (United States), European Commission programmes, and global initiatives such as the WHO Framework Convention on Tobacco Control.

Congress structure and themes

The Congress programme is organised into plenaries, symposia and workshops featuring leaders from World Health Organization, researchers from International Agency for Research on Cancer, clinicians from European Society for Medical Oncology and representatives of advocacy groups such as American Cancer Society and Cancer Research UK. Themes have included implementation science championed by Bill & Melinda Gates Foundation, health systems strengthening promoted by World Bank, tobacco control echoing WHO Framework Convention on Tobacco Control, vaccination programmes aligned with GAVI, the Vaccine Alliance and survivorship models discussed with inputs from Macmillan Cancer Support and LIVESTRONG Foundation. The Congress routinely includes sessions on cancer genomics with contributions from Broad Institute, Wellcome Sanger Institute and National Human Genome Research Institute, alongside policy fora involving European Commission, African Union and regional agencies like Pan American Health Organization.

Membership and participation

Participation spans UICC member organisations including national cancer societies such as American Cancer Society, Cancer Council Australia, Canadian Cancer Society and clinical networks from ASCO, ESMO, IASLC as well as research institutions like Dana-Farber Cancer Institute, MD Anderson Cancer Center, Peter MacCallum Cancer Centre and Tokyo Cancer Institute. Delegates include Ministers of Health from states represented in United Nations General Assembly, senior executives from multilateral institutions including World Bank and WHO, patient advocates from groups like African Cancer Coalition and philanthropic leaders from Wellcome Trust and Gates Foundation. Industry presence has included representatives from multinational pharmaceutical companies such as Roche, Novartis, Pfizer and diagnostics firms including Roche Diagnostics.

Key outcomes and initiatives

The Congress has catalysed policy declarations, partnership frameworks and deliverables aligned with global commitments like the Sustainable Development Goals and WHO cancer initiatives. Outcomes have included calls to scale up national cancer control plans endorsed by ministries and civil society, multi-stakeholder partnerships with agencies such as GAVI and donors like Bloomberg Philanthropies, and knowledge transfer initiatives linking institutions such as MD Anderson Cancer Center and Institut Gustave Roussy to low- and middle-income country programmes coordinated with World Health Organization regional offices and the Global Fund. Research prioritisation efforts have connected funders including Wellcome Trust and European Research Council with investigators at Harvard Medical School, Karolinska Institutet and University of Cape Town.

Notable Congresses and hosts

Past Congresses have been hosted in major international cities and venues associated with global diplomacy and science, engaging hosts such as Government of France in Paris, City of Sydney with support from Cancer Council Australia, Government of Canada in Montreal with involvement from Canadian Cancer Society, and events in locations that engaged regional partners such as South African Department of Health in Cape Town and Japan Ministry of Health, Labour and Welfare in Tokyo. Notable sessions have drawn leaders including heads of organisations like World Health Organization Director-General, chairs from Union for International Cancer Control and senior figures from Bill & Melinda Gates Foundation and Bloomberg Philanthropies.

Category:Cancer conferences